Renalytix AI plc , a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of…

Parties to adopt multi-phase approach to develop precision medicine strategies to optimize treatment of cardiovascular, renal and metabolic disease…

Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to…

RenalytixAI plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive…

Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to…

Effective October 16, KidneyinteIX Will Be Covered for Reimbursement for Qualified Members Renalytix AI plc, a developer of artificial intelligence…

Company Expands Leadership Team with Focus on Reimbursement for Artificial Intelligence Clinical in Vitro Diagnostic, KidneyinteIX Renalytix AI…

Data Development Plan Review Continues with FDA Under Breakthrough Device Designation Process; Performance Meets or Exceeds Targets for Identifying…

Investigators Now Include Transplant Experts from University of Oxford, Yale School of Medicine, Emory University School of Medicine, Icahn School of…

RenalytixAI, a developer of artificial intelligence-enabled diagnostics for kidney disease, announced the completion of a joint venture partnership…